Green Tea Market to Surpass USD 38.7 Billion by 2032 with 7.9% CAGR
The global Green Tea market has witnessed remarkable growth over the past decade, supported by rising consumer awareness regarding wellness, antioxidants, and preventive healthcare. In 2023, the global green tea market was valued at approximately USD 17.8 billion and is projected to exceed USD 38.7 billion by 2032, expanding at a CAGR of 7.9% during the forecast period. Global green tea production surpassed 6.6 million metric tons in 2024, with Asia-Pacific contributing nearly 73% of the total output. Increasing demand for organic beverages, weight management products, and herbal drinks continues to accelerate green tea market expansion.
Green Tea Market Historical Performance and 10-Year Growth Trend
Between 2015 and 2024, the green tea market expanded steadily due to rising disposable incomes and shifting dietary preferences. In 2015, the market size stood near USD 9.4 billion, increasing to USD 12.7 billion in 2018, representing a growth rate of nearly 35% over three years. By 2020, the market crossed USD 14.3 billion despite pandemic-related supply chain disruptions.
From 2021 to 2024, the green tea market grew from USD 15.6 billion to USD 17.8 billion, indicating a 14.1% increase within four years. Historical consumption patterns show that global per capita tea intake rose by 11% during the last decade. Green tea consumption specifically increased by approximately 28% globally from 2016 to 2024 due to changing health priorities.
The market’s growth has also been supported by product diversification. Matcha-based beverages, flavored green tea variants, and ready-to-drink products collectively contributed nearly 39% of green tea market revenue in 2024.
Year-Over-Year Green Tea Market Growth and Revenue Comparisons
The green tea market has maintained stable annual growth over the past five years. In 2020, the market generated approximately USD 14.3 billion. Revenue increased to USD 15.1 billion in 2021, reflecting a 5.6% year-over-year rise.
By 2022, global revenue reached USD 16.2 billion, marking a 7.3% increase compared to the previous year. The market achieved USD 17.0 billion in 2023, growing by 4.9% year-over-year. In 2024, green tea market valuation climbed to nearly USD 17.8 billion, representing another 4.7% annual increase.
The premium green tea segment showed stronger expansion, recording an annual growth rate above 8.4% between 2020 and 2024. Organic green tea products experienced an even faster growth trajectory, rising by nearly 10.8% annually due to consumer demand for chemical-free products.
Green Tea Market Segmentation by Product Type and Distribution Channel
Loose-leaf green tea accounted for nearly 41% of global market share in 2024, generating more than USD 7.2 billion in annual revenue. Tea bags represented 34% market share, while ready-to-drink green tea beverages contributed approximately 19%.
Organic green tea products held nearly 22% of the green tea market in 2024, compared to only 14% in 2018. This reflects a six-year increase of approximately 57%. Functional green tea products enriched with vitamins and probiotics contributed nearly USD 2.1 billion to total market revenue.
In terms of distribution channels, supermarkets and hypermarkets captured approximately 44% of global sales. Online retail channels represented 21% of the green tea market in 2024, rising significantly from 9% in 2017. E-commerce-driven green tea sales increased by nearly 133% over seven years.
Convenience stores contributed nearly 18% of market sales, while specialty tea retailers accounted for approximately 11%. Direct-to-consumer subscription tea services also gained traction, growing by nearly 12.5% annually.
Regional Green Tea Market Analysis and Country-Level Statistics
Asia-Pacific dominates the green tea market, accounting for nearly 63% of global revenue in 2024. The region generated approximately USD 11.2 billion in revenue due to strong consumption across China, Japan, India, and South Korea.
China remains the largest green tea producer globally, contributing over 49% of world production. Chinese green tea exports exceeded USD 1.8 billion in 2024. Japan produced approximately 88,000 metric tons of green tea annually, while India’s green tea production crossed 220,000 metric tons.
North America represented nearly 16% of the global green tea market in 2024. The United States alone generated approximately USD 2.4 billion in green tea revenue. Increasing demand for functional beverages pushed annual green tea consumption growth above 6.8% in the region.
Europe held approximately 13% market share, supported by growing interest in herbal drinks and antioxidant-rich beverages. Germany, the United Kingdom, and France collectively accounted for nearly 54% of Europe’s green tea consumption.
The Middle East and Africa contributed approximately 5% of global green tea revenue. Rising urbanization and wellness-focused lifestyles helped annual demand grow by nearly 6.2% across these regions.
Green Tea Industry Trends, Investments, and Consumer Statistics
The green tea market has benefited significantly from health-oriented consumer behavior. According to beverage industry surveys, nearly 64% of consumers prefer natural drinks over carbonated beverages. Around 58% of millennials reported choosing antioxidant-rich beverages at least twice per week.
Global investments in tea processing technology exceeded USD 2.6 billion between 2020 and 2024. Automated packaging facilities increased by approximately 31% globally during the same period.
Governments have also supported tea cultivation. India allocated approximately USD 160 million toward tea plantation modernization programs between 2021 and 2025. China invested nearly USD 450 million in sustainable tea farming initiatives over the last five years.
Functional beverages featuring green tea extracts expanded rapidly, growing by nearly 9.3% annually. Green tea supplements and nutraceutical products generated approximately USD 3.1 billion globally in 2024.
Company Market Share and Competitive Landscape
Leading companies dominate a significant share of the green tea market. The top five tea brands collectively controlled nearly 34% of global revenue in 2024. Large beverage manufacturers expanded their green tea portfolios to capture premium segments.
Japanese tea companies recorded annual export growth rates above 8%. Premium matcha brands achieved profit margins ranging between 18% and 24%. Several multinational beverage companies invested heavily in ready-to-drink green tea beverages, increasing production capacity by nearly 27% over the past three years.
Private-label tea products gained momentum, contributing nearly USD 2.7 billion in annual revenue. Retailers launched affordable green tea product lines to attract price-sensitive consumers.
Future Outlook and Green Tea Market Forecast Through 2032
The green tea market is expected to maintain strong momentum due to rising wellness trends, aging populations, and increasing functional beverage demand. By 2027, the market is projected to exceed USD 24.9 billion. Revenue could cross USD 31.5 billion by 2030 and reach approximately USD 38.7 billion by 2032.
Asia-Pacific is expected to retain dominance, with regional revenue projected to surpass USD 23 billion by 2032. North America could witness CAGR growth of 8.2%, while Europe may maintain annual expansion near 6.5%.
Ready-to-drink green tea beverages are forecast to grow at nearly 9.1% CAGR through 2032. Organic green tea products could surpass USD 9.8 billion in annual revenue by the end of the forecast period.
The green tea market remains one of the fastest-growing segments within the global beverage industry. Historical growth patterns, rising investments, consumer health awareness, and premium product innovation continue to support expansion. With revenue projected to more than double between 2024 and 2032, the green tea market offers significant opportunities across manufacturing, retail, exports, and wellness-focused product categories.
Read Full Research Study: https://marketintelo.com/report/green-tea-market
###
Sponsor Message
For millions of Americans, Canadian pharmacies provide an affordable solution for essential prescriptions such as Lipitor and Crestor to manage cholesterol, or Nexium for GERD and acid reflux. Chronic conditions such as diabetes and respiratory illnesses are managed with medications like Humalog, Lantus, Advair Diskus, and Ventolin inhalers. Trusted drugs like Zoloft, Prozac, and Abilify are vital for mental health, while Eliquis, Plavix, and Xarelto help protect cardiovascular health. Frequently ordered medications include Celebrex for pain and inflammation and Synthroid for thyroid support. Additionally, Viagra and Cialis are common treatments for erectile dysfunction, while Januvia plays a critical role in managing Type 2 diabetes. People with excessive sleepiness or narcolepsy depend on medications like Provigil and Nuvigil to stay awake and alert. Patients across the U.S. can access affordable medications like Cymbalta for nerve pain and Aricept for Alzheimer's through Canadian pharmacies.
